Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,297 | 13,100 | 6,285 | 7,832 | 7,231 |
| Receivables | N/A | 300 | N/A | N/A | N/A |
| TOTAL | $8,780 | $13,629 | $7,139 | $8,480 | $7,849 |
| Non-Current Assets | |||||
| PPE Net | 287 | 313 | 335 | 362 | 359 |
| Other Non-Current Assets | 3,881 | 70 | 48 | 48 | 48 |
| TOTAL | $4,168 | $383 | $383 | $410 | $407 |
| Total Assets | $12,947 | $14,012 | $7,522 | $8,889 | $8,255 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 934 | 1,055 | 1,087 | 590 | 630 |
| Accrued Expenses | 1,847 | 1,686 | 827 | 600 | 1,058 |
| TOTAL | $3,308 | $2,801 | $1,966 | $1,308 | $1,871 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,008 | 3,748 | 3,456 | 3,165 | 2,882 |
| TOTAL | $8,013 | $4,136 | $3,863 | $3,592 | $3,162 |
| Total Liabilities | $11,322 | $6,937 | $5,829 | $4,900 | $5,034 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,419 | 1,419 | 1,036 | 1,034 | 860 |
| Common Shares | 43 | 43 | 31 | 29 | 23 |
| Retained earnings | -187,343 | -181,133 | -175,410 | -168,193 | -160,758 |
| Other shareholders' equity | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $1,626 | $7,075 | $1,693 | $3,989 | $3,222 |
| Total Liabilities And Equity | $12,947 | $14,012 | $7,522 | $8,889 | $8,255 |